TLCR Reading Tools
How to cite item
The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{64755}, author = {Zhao, Y., Wang, Q., Zhang, L., Shi, J., Wang, Z., Cheng, Y., He, J., Shi, Y., Chen, W., Luo, Y., Wu, L., Wang, X., Nan, K., Jin, F., Dong, J., Li, B., Yamaguchi, F., Breadner, D., Nagano, T., Tanaka, F., Husain, H., Li, K., Han, B.}, title = {The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study}, journal = {Translational Lung Cancer Research}, volume = {11}, number = {5}, year = {2022}, url = {https://tlcr.amegroups.org/article/view/64755} }